Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: The EPICOR study

Licia Iacoviello, Claudia Agnoli, Amalia De Curtis, Augusto Di Castelnuovo, Maria Concetta Giurdanella, Vittorio Krogh, Amalia Mattiello, Giuseppe Matullo, Carlotta Sacerdote, Rosario Tumino, Paolo Vineis, Giovanni De Gaetano, Salvatore Panico, Maria Benedetta Donati

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: The EPICOR study'. Together they form a unique fingerprint.

Medicine & Life Sciences